Skip to main content
Top

07-05-2024 | Primary Sclerosing Cholangitis | Original Article—Alimentary Tract

What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?

Authors: Yuichi Kano, Takuya Ishikawa, Kentaro Yamao, Yasuyuki Mizutani, Tadashi Iida, Kota Uetsuki, Takeshi Yamamura, Kazuhiro Furukawa, Masanao Nakamura, Hiroki Kawashima

Published in: Journal of Gastroenterology

Login to get access

Abstract

Background

In primary sclerosing cholangitis (PSC), it is important to understand the cholangiographic findings suggestive of malignancy, but it is difficult to determine whether cholangiocarcinoma is present due to modifications caused by inflammation. This study aimed to clarify the appropriate method of pathological specimen collection during endoscopic retrograde cholangiopancreatography for surveillance of PSC.

Methods

A retrospective observational study was performed on 59 patients with PSC. The endpoints were diagnostic performance for benign or malignant on bile cytology and transpapillary bile duct biopsy, cholangiographic findings of biopsied bile ducts, diameters of the strictures and upstream bile ducts, and their differences.

Results

The sensitivity (77.8% vs. 14.3%, P = 0.04), specificity (97.8% vs. 83.0%, P = 0.04), and accuracy (94.5% vs. 74.1%, P = 0.007) were all significantly greater for bile duct biopsy than for bile cytology. All patients with cholangiocarcinoma with bile duct stricture presented with dominant stricture (DS). The diameter of the upstream bile ducts (7.1 (4.2–7.2) mm vs. 2.1 (1.2–4.1) mm, P < 0.001) and the diameter differences (6.6 (3.1–7) mm vs. 1.5 (0.2–3.6) mm, P < 0.001) were significantly greater in the cholangiocarcinoma group than in the noncholangiocarcinoma group with DS. For diameter differences, the optimal cutoff value for the diagnosis of benign or malignant was 5.1 mm (area under the curve = 0.972).

Conclusion

Transpapillary bile duct biopsy should be performed via localized DS with upstream dilation for the detection of cholangiocarcinoma in patients with PSC. Especially when the diameter differences are greater than 5 mm, the development of cholangiocarcinoma should be strongly suspected.
Literature
1.
go back to reference Isayama H, Tazuma S, Kokudo N, et al. Clinical guidelines for primary sclerosing cholangitis 2017: the Intractable Hepatobiliary Disease Study Group. J Gastroenterol. 2018;53:1006–34.CrossRefPubMedPubMedCentral Isayama H, Tazuma S, Kokudo N, et al. Clinical guidelines for primary sclerosing cholangitis 2017: the Intractable Hepatobiliary Disease Study Group. J Gastroenterol. 2018;53:1006–34.CrossRefPubMedPubMedCentral
2.
go back to reference Burak K, Angulo P, Pasha TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523–6.CrossRefPubMed Burak K, Angulo P, Pasha TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523–6.CrossRefPubMed
3.
go back to reference Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in primary sclerosing cholangitis: a population-based study. Scand J Gastroenterol. 1997;32:1042–5.CrossRefPubMed Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in primary sclerosing cholangitis: a population-based study. Scand J Gastroenterol. 1997;32:1042–5.CrossRefPubMed
4.
go back to reference Song J, Li Y, Bowlus CL, et al. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a comprehensive review. Clin Rev Allergy Immunol. 2020;58:134–49.CrossRefPubMed Song J, Li Y, Bowlus CL, et al. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a comprehensive review. Clin Rev Allergy Immunol. 2020;58:134–49.CrossRefPubMed
5.
go back to reference Hand F, Hoti E. Contemporary role of liver transplantation for the treatment of cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2020;14:475–81.CrossRefPubMed Hand F, Hoti E. Contemporary role of liver transplantation for the treatment of cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2020;14:475–81.CrossRefPubMed
6.
go back to reference Heimbach JK, Haddock MG, Alberts SR, et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl. 2004;10:S65–8.CrossRefPubMed Heimbach JK, Haddock MG, Alberts SR, et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl. 2004;10:S65–8.CrossRefPubMed
7.
8.
go back to reference Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58:2045–55.CrossRefPubMed Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58:2045–55.CrossRefPubMed
9.
go back to reference European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–67.CrossRef European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–67.CrossRef
10.
go back to reference Nakazawa T, Notohara K, Tazuma S, et al. The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol. 2017;52:838–44.CrossRefPubMed Nakazawa T, Notohara K, Tazuma S, et al. The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol. 2017;52:838–44.CrossRefPubMed
11.
go back to reference Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–93.CrossRefPubMed Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–93.CrossRefPubMed
12.
go back to reference Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed
13.
go back to reference Njei B, McCarty RT, Varadarajulu S, et al. Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Aliment Pharmacol Ther. 2016;44:1139–51.CrossRefPubMed Njei B, McCarty RT, Varadarajulu S, et al. Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Aliment Pharmacol Ther. 2016;44:1139–51.CrossRefPubMed
14.
go back to reference Kalaitzakis E, Sturgess R, Kaltsidis H, et al. Diagnostic utility of single-user peroral cholangioscopy in sclerosing cholangitis. Scand J Gastroenterol. 2014;49:1237–44.CrossRefPubMed Kalaitzakis E, Sturgess R, Kaltsidis H, et al. Diagnostic utility of single-user peroral cholangioscopy in sclerosing cholangitis. Scand J Gastroenterol. 2014;49:1237–44.CrossRefPubMed
15.
go back to reference Navaneethan U, Njei B, Lourdusamy V, et al. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81:168–76.CrossRefPubMed Navaneethan U, Njei B, Lourdusamy V, et al. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81:168–76.CrossRefPubMed
16.
go back to reference Kawashima H, Itoh A, Ohno E, et al. Transpapillary biliary forceps biopsy to distinguish benign biliary stricture from malignancy: how many tissue samples should be obtained? Dig Endosc. 2012;24:22–7.CrossRefPubMed Kawashima H, Itoh A, Ohno E, et al. Transpapillary biliary forceps biopsy to distinguish benign biliary stricture from malignancy: how many tissue samples should be obtained? Dig Endosc. 2012;24:22–7.CrossRefPubMed
17.
go back to reference Aoki T, Ohno E, Ishikawa T, et al. Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma. BMC Gastroenterol. 2022;22:329.CrossRefPubMedPubMedCentral Aoki T, Ohno E, Ishikawa T, et al. Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma. BMC Gastroenterol. 2022;22:329.CrossRefPubMedPubMedCentral
18.
go back to reference Kawashima H, Itoh A, Ohno E, et al. Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma. J Hepatobil Pancreat Sci. 2013;20:441–7.CrossRef Kawashima H, Itoh A, Ohno E, et al. Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma. J Hepatobil Pancreat Sci. 2013;20:441–7.CrossRef
19.
go back to reference Chapman MH, Webster GJM, Bannoo S, et al. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol. 2012;24:1051–8.CrossRefPubMedPubMedCentral Chapman MH, Webster GJM, Bannoo S, et al. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol. 2012;24:1051–8.CrossRefPubMedPubMedCentral
20.
go back to reference Gotthardt DN, Rudolph G, Kloeters-Plachky P, et al. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc. 2010;71:527–34.CrossRefPubMed Gotthardt DN, Rudolph G, Kloeters-Plachky P, et al. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc. 2010;71:527–34.CrossRefPubMed
Metadata
Title
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?
Authors
Yuichi Kano
Takuya Ishikawa
Kentaro Yamao
Yasuyuki Mizutani
Tadashi Iida
Kota Uetsuki
Takeshi Yamamura
Kazuhiro Furukawa
Masanao Nakamura
Hiroki Kawashima
Publication date
07-05-2024
Publisher
Springer Nature Singapore
Published in
Journal of Gastroenterology
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-024-02105-y
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine